Insider Selling: Omega Healthcare Investors, Inc. (NYSE:OHI) COO Sells $2,283,181.25 in Stock

Omega Healthcare Investors, Inc. (NYSE:OHI) COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Omega Healthcare Investors Stock Performance

Shares of NYSE:OHI opened at $39.98 on Friday. The company has a quick ratio of 5.79, a current ratio of 5.79 and a debt-to-equity ratio of 1.19. The company has a market capitalization of $10.31 billion, a price-to-earnings ratio of 36.02, a price-to-earnings-growth ratio of 1.30 and a beta of 1.00. The firm has a 50 day moving average of $39.04 and a 200 day moving average of $34.55. Omega Healthcare Investors, Inc. has a 52 week low of $27.53 and a 52 week high of $41.53.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings data on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). The company had revenue of $252.70 million for the quarter, compared to the consensus estimate of $205.92 million. Omega Healthcare Investors had a net margin of 33.52% and a return on equity of 8.61%. Omega Healthcare Investors’s revenue for the quarter was up 17.5% compared to the same quarter last year. During the same period in the previous year, the business earned $0.74 EPS. On average, sell-side analysts predict that Omega Healthcare Investors, Inc. will post 2.69 earnings per share for the current fiscal year.

Omega Healthcare Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Monday, August 5th were issued a dividend of $0.67 per share. The ex-dividend date of this dividend was Monday, August 5th. This represents a $2.68 annualized dividend and a dividend yield of 6.70%. Omega Healthcare Investors’s dividend payout ratio is presently 241.44%.

Institutional Investors Weigh In On Omega Healthcare Investors

Several institutional investors have recently added to or reduced their stakes in the business. Park Avenue Securities LLC increased its stake in Omega Healthcare Investors by 59.3% during the 3rd quarter. Park Avenue Securities LLC now owns 17,088 shares of the real estate investment trust’s stock valued at $695,000 after purchasing an additional 6,360 shares in the last quarter. SG Americas Securities LLC purchased a new position in shares of Omega Healthcare Investors in the third quarter worth about $1,288,000. NCP Inc. lifted its holdings in shares of Omega Healthcare Investors by 10.3% during the second quarter. NCP Inc. now owns 3,310 shares of the real estate investment trust’s stock worth $113,000 after purchasing an additional 310 shares during the period. B. Riley Wealth Advisors Inc. boosted its position in Omega Healthcare Investors by 297.4% in the second quarter. B. Riley Wealth Advisors Inc. now owns 37,516 shares of the real estate investment trust’s stock valued at $1,285,000 after buying an additional 28,075 shares during the last quarter. Finally, Regal Investment Advisors LLC increased its holdings in Omega Healthcare Investors by 10.6% in the 2nd quarter. Regal Investment Advisors LLC now owns 7,037 shares of the real estate investment trust’s stock worth $241,000 after buying an additional 677 shares during the period. Institutional investors and hedge funds own 65.25% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the company. Truist Financial lifted their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research report on Wednesday, September 4th. Wells Fargo & Company reiterated an “overweight” rating and set a $43.00 price objective (up previously from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday. Scotiabank raised their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research report on Monday, August 26th. Finally, Mizuho downgraded shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and lifted their price target for the company from $34.00 to $35.00 in a research note on Thursday, July 25th. Seven equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $36.00.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.